Effectiveness of carvedilol alone versus carvedilol + pimobendan for severe congestive heart failure. For the Keio Interhospital Cardiology Study (KICS) Group

Am J Cardiol. 2000 Jun 15;85(12):1495-7; A7. doi: 10.1016/s0002-9149(00)00803-1.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology
  • Adrenergic beta-Antagonists / therapeutic use*
  • Carbazoles / pharmacology
  • Carbazoles / therapeutic use*
  • Cardiotonic Agents / pharmacology
  • Cardiotonic Agents / therapeutic use*
  • Carvedilol
  • Drug Therapy, Combination
  • Female
  • Heart Failure / drug therapy*
  • Heart Failure / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Propanolamines / pharmacology
  • Propanolamines / therapeutic use*
  • Pyridazines / pharmacology
  • Pyridazines / therapeutic use*
  • Ventricular Function, Left / drug effects

Substances

  • Adrenergic beta-Antagonists
  • Carbazoles
  • Cardiotonic Agents
  • Propanolamines
  • Pyridazines
  • Carvedilol
  • pimobendan